Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Director departure
Inv. presentation

Targeted Medical Pharma, Inc. (TRGM) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/22/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/12/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/01/2015 8-K Quarterly results
03/03/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "To the Board of Targeted Medical Pharma, Inc. and"
02/27/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note",
"Promissory Note"
02/06/2015 8-K Resignation/termination of a director
01/20/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Securities Purchase Agreement",
"Form of Senior Secured Convertible Debenture",
"Form of Security Agreement"
01/12/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/06/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/11/2014 8-K Submission of Matters to a Vote of Security Holders
05/20/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation"
04/01/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation"
03/11/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Healthcare Executive Dr. Thomas Wenkart Joins Targeted Medical Pharma’ s Board of Directors Los Angeles, March 5, 2014 –Targeted Medical Pharma, Inc. today announced that Dr. Thomas Wenkart, Chief Executive and Chairman at Macquarie Health Corporation, has joined the company’ s board of directors. A nationally respected expert in healthcare, medical and hospital administration in Australia, Dr. Wenkart established Macquarie Health Corporation in Sydney, Australia in 1976. His organization owns and operates eleven private hospitals in Australia, and is one of the nation’ s leading providers of healthcare services. Dr. Wenkart is a graduate of the Sydney University School of Medicine. In 1976, he established the Health Care Research Institute and the Wenkart Foundation which supports the Art...",
"Dr. Tom Wenkart - Bio"
01/02/2014 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Form of WC Receivables Funding, Assignment and Security Agreement",
"Amendment No. 1 to Employment Agreement with William B. Horne"
10/07/2013 8-K Form 8-K - Current report
09/09/2013 8-K Form 8-K - Current report
08/21/2013 8-K Appointed CFO
Docs: "Employment Agreement, effective as of August 19, 2013, by and between the Company and William B. Horne",
"Targeted Medical Pharma Selects William B. Horne as Chief Financial officer Los Angeles, August 21, 2013, Targeted Medical Pharma, Inc. , a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company’ s Chief Financial Officer. He will oversee all aspects of the company’ s fiscal operations and financial reporting.",
"Targeted Medical Pharma Selects William B. Horne as Chief Financial officer Los Angeles, August 21, 2013, Targeted Medical Pharma, Inc. , a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the appointment of William B. Horne as the company’ s Chief Financial Officer. He will oversee all aspects of the company’ s fiscal operations and financial reporting."
08/01/2013 8-K Form 8-K - Current report
07/03/2013 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Common Stock Warrant",
"Workers’ Compensation Receivables Funding, Assignment and Security Agreement",
"Professional Services and Consulting Agreement",
"Professional Services and Consulting Agreement"
06/12/2013 8-K Form 8-K - Current report
05/20/2013 8-K Resignation/termination of a director
04/23/2013 8-K Investor presentation
Docs: "Targeted Medical Pharma Pre-announces 2013 Unaudited Q1 Revenue",
"Presentation"
04/18/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Media Contacts:"
03/21/2013 8-K Form 8-K - Current report
02/13/2013 8-K Other Events, Financial Statements and Exhibits
Docs: "Targeted medical pharma Is assigned comprehensive Pharmaceutical BIlling PATENT"
01/07/2013 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Presentation",
"FIVE Targeted Medical Pharma Products LISTED on U.S. Dept. of Veterans Affairs’ Federal Supply Schedule"
11/29/2012 8-K Form 8-K - Current report
11/07/2012 8-K Form 8-K - Current report
10/05/2012 8-K Form 8-K - Current report
08/16/2012 8-K/A Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
08/07/2012 8-K Form 8-K - Current report
07/18/2012 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy